Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus:: Implications for HCV therapy in HCV/HIV-coinfected patients

被引:31
作者
Ramos, Belen
Nunez, Marina
Toro, Carlos
Sheldon, Julie
Garcia-Samaniego, Javier
Rios, Pilar
Soriano, Vincent
机构
[1] Hosp Carlos III, Dept Infect Dis, Madrid 28029, Spain
[2] Hosp Carlos III, Hepatol Unit, Madrid 28029, Spain
关键词
HCV; HIV; genotype; interferon; liver;
D O I
10.1016/j.jinf.2006.02.006
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
Background: Changes in the prevalence of distinct hepatitis C virus (HCV) genotypes and subtypes over time have not been explored in detail. Methods: A retrospective analysis was carried out in all specimens from subjects with chronic hepatitis C sent for testing to a reference laboratory in Spain since 1998-2004. Results: A total of 1226 distinct subjects were analyzed. The most frequent HCV genotype was 1 (64.1%), followed by 3 (20.9%) and 4 (11.7%). The most frequent HCV subtype was 1b (32.4%). A total of 797 patients (65%) were HIV-positive. Although genotype 1 was the most frequent, it represented 74.6% of HIV-negative and 58.5% of HIV-positive patients (p < 0.01). White HCV subtype la was the most frequent among HIV-positive subjects (32.1%), 1b was the most common in HIV-negative patients (53.8%). There was a significant increase in the prevalence of genotype 4 and conversely a decline in genotype 3 among HIV-positive patients over time. Conclusion: Genotype 1 is the most frequent HCV variant circulating in Spain. Genotypes 3 and 4 are significantly more prevalent in HIV/HCV-coinfected than in HCV-monoinfected patients. However, HCV-3 has declined and HCV-4 is increasing in the former group. These findings are relevant given their different susceptibility to interferon-based therapies. (C) 2006 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:173 / 179
页数:7
相关论文
共 38 条
[1]
Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients [J].
Adinolfi, LE ;
Utili, R ;
Andreana, A ;
Tripodi, MF ;
Rosario, P ;
Mormone, G ;
Ragone, E ;
Pasquale, G ;
Ruggiero, G .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (03) :299-304
[2]
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562
[3]
Different seroprevalence and molecular epidemiology patterns of hepatitis c virus infection in Italy [J].
Ansaldi, F ;
Bruzzone, B ;
Salmaso, S ;
Rota, MC ;
Durando, P ;
Gasparini, R ;
Icardi, G .
JOURNAL OF MEDICAL VIROLOGY, 2005, 76 (03) :327-332
[4]
Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: Correlation with clinical and virological parameters [J].
Berg, T ;
Hopf, U ;
Stark, K ;
Baumgarten, R ;
Lobeck, H ;
Schreier, E .
JOURNAL OF HEPATOLOGY, 1997, 26 (03) :484-491
[5]
Blatt LM, 2000, J VIRAL HEPATITIS, V7, P196
[6]
Genotyping of hepatitis C virus isolates from Basque Country, Spain [J].
Cilla, G ;
GarciaBengoechea, M ;
PerezTrallero, E ;
Montalvo, I ;
Vicente, D ;
Arenas, JI .
EPIDEMIOLOGY AND INFECTION, 1996, 117 (03) :533-536
[7]
Changing molecular epidemiology of hepatitis C virus infection in northeast Italy [J].
Dal Molin, G ;
Ansaldi, F ;
Biagi, C ;
D'Agaro, P ;
Comar, M ;
Crocè, L ;
Tiribelli, C ;
Campello, C .
JOURNAL OF MEDICAL VIROLOGY, 2002, 68 (03) :352-356
[8]
Significance of hepatitis C virus coinfection with persistently normal alanine aminotransferase levels in HIV-1-infected patients [J].
Fonquernie, L ;
Serfaty, L ;
Charrois, A ;
Wendum, D ;
Lefebvre, B ;
Girard, PM ;
Meynard, JL .
HIV MEDICINE, 2004, 5 (05) :385-390
[9]
García F, 1998, MICROBIOS, V95, P15
[10]
Guettouche T, 2005, ANTIVIR THER, V10, P593